Literature DB >> 15125796

Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation.

Birgit Görtz1, Silvia Hayer, Kurt Redlich, Jochen Zwerina, Makyieh Tohidast-Akrad, Birgit Tuerk, Christine Hartmann, George Kollias, Günter Steiner, Josef S Smolen, Georg Schett.   

Abstract

UNLABELLED: Arthritis can destroy the cortical bone barrier and expose bone marrow to synovial tissue. This study examines bone marrow changes in arthritis and its effects on cortical bone remodeling. Bone marrow next to arthritic lesions exhibits B-lymphocyte-rich infiltrates, which express BMPs and stimulate endosteal bone formation. Thus, bone marrow actively participates in the arthritic process.
INTRODUCTION: Imaging studies have shown that bone marrow changes occur in patients with rheumatoid arthritis (RA). To examine whether bone marrow is affected during arthritis, human TNF transgenic (hTNFtg) mice, which constitute an established animal model of human RA, were examined for bone marrow changes.
MATERIALS AND METHODS: The hind paws (tarsal area) of 22 untreated hTNFtg mice, 5 hTNFtg mice treated with anti-TNF (infliximab), and 5 wildtype (WT) mice were examined histologically, immunohistochemically, and by means of mRNA in situ hybridization. RESULTS AND
CONCLUSIONS: All untreated hTNFtg mice with moderate (n = 10) and severe (n = 7) disease developed inflammatory bone marrow lesions during the course of disease, whereas no such lesions appeared in hTNFtg mice with mild disease (n = 5) and WT mice. Bone marrow infiltrates were almost exclusively composed of lymphocytes, and the overwhelming proportion (>80%) was B-cells. Presence and extent of bone marrow infiltrates were closely linked to severity of arthritis. In addition, blockade of TNF effectively reduced bone marrow inflammation. Interestingly, osteoblast numbers were increased at the endosteal surface in the vicinity of these lesions. Moreover, osteoid deposition; expression of bone matrix proteins, such as osteocalcin and osteopontin; and mineralization were enhanced, suggesting that inflammatory bone marrow infiltrates induce bone formation. Indeed, B-lymphocytes of these lesions expressed bone morphogenetic protein (BMP)-6 and -7, which are important stimulators of new bone formation. Thus, we conclude that bone marrow actively participates in destructive arthritis by generating B-lymphocyte-rich bone marrow lesions and inducing endosteal bone formation. Copyright 2004 American Society for Bone and Mineral Research

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15125796     DOI: 10.1359/JBMR.040205

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

Review 1.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy.

Authors:  Jie Li; Igor Kuzin; Safiehkhatoon Moshkani; Steven T Proulx; Lianping Xing; Denise Skrombolas; Robert Dunn; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

3.  Highly osteogenic PDL stem cell clones specifically express elevated levels of ICAM1, ITGB1 and TERT.

Authors:  Laddawun Sununliganon; Weerachai Singhatanadgit
Journal:  Cytotechnology       Date:  2011-08-25       Impact factor: 2.058

4.  Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw.

Authors:  Dan Li; Kirill Gromov; Steven T Proulx; Chao Xie; Jie Li; Daniel P Crane; Kjeld Søballe; Regis J O'Keefe; Hani A Awad; Lianping Xing; Edward M Schwarz
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

5.  Inflammation in arthritis induces expression of BMP3, an inhibitor of bone formation.

Authors:  M M Matzelle; A T Shaw; R Baum; Y Maeda; J Li; S Karmakar; C A Manning; N C Walsh; V Rosen; E M Gravallese
Journal:  Scand J Rheumatol       Date:  2016-03-16       Impact factor: 3.641

6.  Biocompatibility of adhesive complex coacervates modeled after the sandcastle glue of Phragmatopoma californica for craniofacial reconstruction.

Authors:  Brent D Winslow; Hui Shao; Russell J Stewart; Patrick A Tresco
Journal:  Biomaterials       Date:  2010-10-14       Impact factor: 12.479

Review 7.  The emerging field of osteoimmunology.

Authors:  Kofi A Mensah; Jie Li; Edward M Schwarz
Journal:  Immunol Res       Date:  2009-01-30       Impact factor: 2.829

Review 8.  B cells in the pathogenesis and treatment of rheumatoid arthritis.

Authors:  Bethany Marston; Arumugam Palanichamy; Jennifer H Anolik
Journal:  Curr Opin Rheumatol       Date:  2010-05       Impact factor: 5.006

9.  Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging.

Authors:  Steven T Proulx; Edmund Kwok; Zhigang You; M Owen Papuga; Christopher A Beck; David J Shealy; Laura M Calvi; Christopher T Ritchlin; Hani A Awad; Brendan F Boyce; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2008-07

Review 10.  Mechanisms of tissue damage in arthritis.

Authors:  Stephan Blüml; Kurt Redlich; Josef S Smolen
Journal:  Semin Immunopathol       Date:  2014-09-12       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.